Angiotensin-converting enzyme (ACE) inhibitors are widely used in cardiovascular disease and have been shown to be associated with beneficial effects on EPCs in severalin vitro and clinical studies11–14. The gene discussed is ACE; the disease is cardiovascular disorder.